author-photo

Joao Victor Machado Alessi

Harvard University

20

Papers

28

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer.

2021 Journal of the National Cancer Institute
Show All
- Source
- Cite
- Save
Citations (6)
Abstract 370: Smoking history as an independent predictor for immune checkpoint inhibitors (ICIs) in metastatic non-small cell lung cancer (NSCLC)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
FP03.03 ECOG PS of 0-1 and Very High PD-L1 Expression ≥90% Are Associated With Clinical Benefit From First-Line Chemo-Immunotherapy in Advanced NSCLC

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy.

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Abstract 490: A very high tumor mutational burden (TMB) is associated with improved efficacy of PD-(L)1 inhibition across different PD-L1 expression subgroups and a distinct immunophenotype in NSCLC

2021
Show All
- Source
- Cite
- Save
Citations (0)
Association of a very high tumor mutational load with increased CD8+ and PD-1+ T-cell infiltration and improved clinical outcomes to PD-(L)1 blockade across different PD-L1 expression levels in non-small cell lung cancer.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Clinicopathologic, genomic, and tumor microenvironment correlates of aneuploidy and immunotherapy outcomes in NSCLC.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Response to Hopkins, Kichenadasse, Logan, et al.

2021 Journal of the National Cancer Institute
Show All
- Source
- Cite
- Save
Citations (0)
Immunotherapy in lung cancer: effective for patients with poor performance status?

2020 The Lancet Respiratory Medicine
- Joao Victor Machado Alessi
- Mark M. Awad
Show All
- Source
- Cite
- Save
Citations (2)
246 Clinicopathologic and genomic correlates of tumor mutational burden and its impact on PD-(L)1 inhibition efficacy in non-small cell lung cancer according to different PD-L1 expression subgroups

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (1)